Jun 27, 2022 | Past Events
Philogen will be Bronze Sponsor of the Post-Chicago Meeting in Münich (30-1 July). Philogen will chair a Satellite Symposium on Friday July 1, 11.30-12.00 am. Dr. Alfredo Covelli, Philogen’s CMO, will give a presentation entitled “Immunocytokines for the therapy...Jun 20, 2022 | Past Events
Philogen held a virtual briefing on 23 June 2022 at 10:00 ET / 15:00 BST / 16:00 CEST following an R&D Update. Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of Investor Relations, hosted a...Mar 29, 2022 | Past Events
Philogen kindly invites you to attend a virtual briefing for analysts on 1 April 2022 to discuss the Company’s Full Year 2021 Financial Results. Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of...Mar 17, 2022 | Past Events
Philogen announces its attendance at the workshop “Il Sistema Ricerca-Industria in Italia” at Accademia dei Lincei (Rome, Italy). Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage targeted...Mar 17, 2022 | Past Events
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”Mar 15, 2022 | Past Events
Philogen is presenting a ePoster entitled “A novel tumor-targeting cytokine-based therapy in combination with lomustine displays promising anti-tumor activity against glioblastoma” Please follow the link below for more information WFNOS 2022...
Recent Comments